Neutrophils eradicate tumors via reactive oxygen species in response to immunotherapy

Placeholder Show Content

Abstract/Contents

Abstract
Although neutrophils are powerful cytotoxic cells capable of killing microbes and injuring host tissues, they are often associated with tumor-promoting inflammation and immunosuppression rather than tumor killing. We demonstrate here that neutrophils can be therapeutically harnessed to eradicate tumors. Following intratumoral co-administration of tumor-binding antibodies, CD40 agonist, and tumor necrosis factor, neutrophils rapidly infiltrate tumors and mediate tumor clearance. This is accomplished through an inflammatory cascade wherein complement activation induces leukotriene B4 (LTB4) production, which in turn activates neutrophil-dependent reactive oxygen species (ROS) production via xanthine oxidase (XO), ultimately resulting in tumor cell death and induction of adaptive anti-tumor immunity. This is interrupted by selective blockade of complement, LTB4, XO, or by scavenging ROS, indicating a necessary role for each of these elements. These results demonstrate the therapeutic capacity of neutrophils to mediate tumor-eradicating immunity and define a mechanism of tumor clearance with multiple promising targets for therapeutic intervention.

Description

Type of resource text
Form electronic resource; remote; computer; online resource
Extent 1 online resource.
Place California
Place [Stanford, California]
Publisher [Stanford University]
Copyright date 2021; ©2021
Publication date 2021; 2021
Issuance monographic
Language English

Creators/Contributors

Author Linde, Ian Lisle
Degree supervisor Engleman, Edgar G
Thesis advisor Engleman, Edgar G
Thesis advisor Davis, Mark M
Thesis advisor Sunwoo, John B
Thesis advisor Winslow, Monte
Degree committee member Davis, Mark M
Degree committee member Sunwoo, John B
Degree committee member Winslow, Monte
Associated with Stanford University, Program in Immunology

Subjects

Genre Theses
Genre Text

Bibliographic information

Statement of responsibility Ian Linde.
Note Submitted to the Program in Immunology.
Thesis Thesis Ph.D. Stanford University 2021.
Location https://purl.stanford.edu/mt842sf8643

Access conditions

Copyright
© 2021 by Ian Lisle Linde

Also listed in

Loading usage metrics...